Loren K Mell, Joel D Kochanski, John C Roeske, Josh J Haslam, Neil Mehta, S Diane Yamada, Jean A Hurteau, Yvonne C Collins, Ernst Lengyel, Arno J Mundt
PURPOSE: To identify dosimetric parameters associated with acute hematologic toxicity (HT) and chemotherapy delivery in cervical cancer patients undergoing concurrent chemotherapy and intensity-modulated pelvic radiotherapy. METHODS AND MATERIALS: We analyzed 37 cervical cancer patients receiving concurrent cisplatin (40 mg/m(2)/wk) and intensity-modulated pelvic radiotherapy. Pelvic bone marrow (BM) was contoured for each patient and divided into three subsites: lumbosacral spine, ilium, and lower pelvis...
December 1, 2006: International Journal of Radiation Oncology, Biology, Physics